Abstract

In in vivo experiments injection of dopamine (DA) or leucine enkephalin (L-Enk) produced hypoglycemia in intact red swamp crayfish, Procambarus clarkii . In contrast neither compound had a significant effect on the circulating glucose concentration in eyestalkless individuals. With intact crayfish spiperone, a DA receptor blocker, inhibited this hypoglycemic action of DA but not this action of L-Enk. In contrast, in intact crayfish naloxone, a competitive opioid antagonist, inhibited the in vivo hypoglycemic actions of both L-Enk and DA. In vitro, both DA and L-Enk reduced the rate of release of the crustacean hyperglycemic hormone (CHH) front isolated eyestalk neuroendocrine tissue. These results suggest that both DA and L-Enk act to inhibit release of CHH by affecting the eyestalk neuroendocrine complex and that the enkephalinergic inhibitory neuron follows the dopaminergic inhibitory neuron in the chain of neurons which leads to the neuroendocrine cells that secrete CHH.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.